Phase
Condition
Diabetes Mellitus, Type 1
Diabetes And Hypertension
Diabetes Prevention
Treatment
Insulin aspart
NNC0471-0119 H
Clinical Study ID
Ages 18-64 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male or female aged 18-64 years (both inclusive) at the time of signing the informedconsent.
Diagnosed with Type 1 Diabetes (T1D) greater than or equal to (≥) 1 year beforescreening.
Insulin administration using continuous subcutaneous insulin infusion via a pumpgreater than or equal to (≥) 90 days before screening.
Current daily insulin treatment between 0.2 and 1.2 Insulin units per kilogram perday [(I)U/kg/day] (both inclusive).
Exclusion
Exclusion Criteria:
Known or suspected hypersensitivity to study intervention(s) or related products.
Female who is pregnant, breast-feeding or intends to become pregnant or is ofchild-bearing potential and not using adequate contraceptive methods.
Study Design
Connect with a study center
Profil Institut für Stoffwechselforschung GmbH
Neuss, 41460
GermanyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.